EBI3/IL-27B dampens IFN-γ driven inflammation by inducing IL-10-producing Tr1 cells, and plasma levels of EBI3/IL-27B are higher in indeterminate/ASY Chagas disease patients than CCC patients. Here, EBI3 is linked to Chagas disease.